Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Tsuda

Showing results (431-440 of 460) with videos related to

Pageof 46
Sort By:
The Journal of Biological Chemistry|December 4, 2008
SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cellsMami Takahata, Yasumichi Inoue, Hitoshi Tsuda, et al.
Breast Cancer (Tokyo, Japan)|October 19, 2021
Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of JapanDaisuke Yotsumoto, Yasuaki Sagara, Hiraku Kumamaru, et al.
American Journal of Cancer Research|January 13, 2025
A novel semi-quantitative scoring method for CD8+ tumor-infiltrating lymphocytes based on infiltration sites in gastric cancerYudai Nakabayashi, Jun Kiuchi, Takeshi Kubota, et al.
Cancer Chemotherapy and Pharmacology|May 12, 2017
Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?Tadashi Aoyama, Masashi Takano, Morikazu Miyamoto, et al.
Scientific Reports|December 8, 2025
Overexpression of JMJD6 drives immune evasion via the BRD4-IRF1-PD-L1 axis and promotes malignancy in gastric cancerRyo Ishida, Shuhei Komatsu, Hajime Kamiya, et al.
Japanese Journal of Clinical Oncology|June 25, 2025
Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancerSatoshi Kano, Naomi Kiyota, Ichiro Kinoshita, et al.
Journal of Gynecologic Oncology|June 19, 2026
Nationwide survey of hereditary breast and ovarian cancer-related clinical practice in gynecologic oncology in Japan: a joint study by the Japan Society of Gynecologic Oncology (JSGO) and the Japan Society of Obstetrics and Gynecology (JSOG)Kenta Masuda, Katsutoshi Oda, Hidemichi Watari, et al.
American Journal of Cancer Research|February 14, 2025
Overexpression of SHANK2 contributes malignant outcomes as a Hippo pathway regulator in gastric cancerHiroshi Arakawa, Shuhei Komatsu, Jun Kiuchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2013
New methods for ALK status diagnosis in non-small-cell lung cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-in situ hybridization assayHiroaki Nitta, Koji Tsuta, Akihiko Yoshida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young womenKimio Ushijima, Hideaki Yahata, Hiroyuki Yoshikawa, et al.
Pageof 46

Showing results (431-440 of 460) with videos related to

Sort By:
Pageof 46
The Journal of Biological Chemistry|December 4, 2008
SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cellsMami Takahata, Yasumichi Inoue, Hitoshi Tsuda, et al.
Breast Cancer (Tokyo, Japan)|October 19, 2021
Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of JapanDaisuke Yotsumoto, Yasuaki Sagara, Hiraku Kumamaru, et al.
American Journal of Cancer Research|January 13, 2025
A novel semi-quantitative scoring method for CD8+ tumor-infiltrating lymphocytes based on infiltration sites in gastric cancerYudai Nakabayashi, Jun Kiuchi, Takeshi Kubota, et al.
Cancer Chemotherapy and Pharmacology|May 12, 2017
Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?Tadashi Aoyama, Masashi Takano, Morikazu Miyamoto, et al.
Scientific Reports|December 8, 2025
Overexpression of JMJD6 drives immune evasion via the BRD4-IRF1-PD-L1 axis and promotes malignancy in gastric cancerRyo Ishida, Shuhei Komatsu, Hajime Kamiya, et al.
Japanese Journal of Clinical Oncology|June 25, 2025
Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancerSatoshi Kano, Naomi Kiyota, Ichiro Kinoshita, et al.
Journal of Gynecologic Oncology|June 19, 2026
Nationwide survey of hereditary breast and ovarian cancer-related clinical practice in gynecologic oncology in Japan: a joint study by the Japan Society of Gynecologic Oncology (JSGO) and the Japan Society of Obstetrics and Gynecology (JSOG)Kenta Masuda, Katsutoshi Oda, Hidemichi Watari, et al.
American Journal of Cancer Research|February 14, 2025
Overexpression of SHANK2 contributes malignant outcomes as a Hippo pathway regulator in gastric cancerHiroshi Arakawa, Shuhei Komatsu, Jun Kiuchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2013
New methods for ALK status diagnosis in non-small-cell lung cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-in situ hybridization assayHiroaki Nitta, Koji Tsuta, Akihiko Yoshida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young womenKimio Ushijima, Hideaki Yahata, Hiroyuki Yoshikawa, et al.
Pageof 46